1Y Close · As of Aug 26, 2026
Kukje Pharma operates in the Pharmaceuticals sector.
Legal name: Kukje Pharma Co., Ltd.
In fiscal year 2025, Kukje Pharma (002720) reported revenue of 175.5 billion KRW, up 12.2% from 156.5 billion KRW a year earlier.
Operating profit was 6.2 billion KRW and net income was 5.7 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 70.5 billion KRW, with a P/B of 0.72.
These figures can be verified in the DART filing (receipt no. 20260318000669).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 175.5B | 6.2B | 5.7B |
| 2024 | 156.5B | 6.7B | 5.2B |
| 2023 | 135.4B | -2.0B | -8.4B |
Recent Filings
Facility Investment
Semi-Annual Report (2026.06)
Large Shareholding Report (General)
Checks
No items require attention at this time.
Market Cap & Price: Market cap is above the delisting threshold.
Administrative Designation: No administrative designation criteria met.
Audit Opinion: Audit opinion: Unqualified (clean).
Convertible Bonds: No convertible bonds outstanding.
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-24 | Facility Investment |
| 2026-08-14 | Semi-Annual Report (2026.06) |
| 2026-08-11 | Large Shareholding Report (General) |